A detailed history of Ubs Group Ag transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Ubs Group Ag holds 1,862 shares of GNTA stock, worth $9,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,862
Previous 893 108.51%
Holding current value
$9,123
Previous $2,000 250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.93 - $4.77 $2,839 - $4,622
969 Added 108.51%
1,862 $7,000
Q2 2024

Aug 13, 2024

BUY
$2.55 - $3.95 $2,172 - $3,365
852 Added 2078.05%
893 $2,000
Q1 2024

May 13, 2024

SELL
$3.14 - $4.84 $7,096 - $10,938
-2,260 Reduced 98.22%
41 $0
Q4 2023

Feb 09, 2024

BUY
$4.7 - $5.59 $10,814 - $12,862
2,301 New
2,301 $11,000
Q2 2023

Aug 11, 2023

BUY
$5.0 - $6.67 $3,500 - $4,669
700 New
700 $4,000
Q4 2022

Feb 08, 2023

BUY
$3.93 - $5.88 $734 - $1,099
187 Added 6.18%
3,215 $17,000
Q3 2022

Nov 10, 2022

BUY
$4.6 - $7.4 $919 - $1,480
200 Added 7.07%
3,028 $15,000
Q2 2022

Aug 10, 2022

BUY
$5.39 - $8.26 $4,662 - $7,144
865 Added 44.07%
2,828 $20,000
Q1 2022

May 16, 2022

SELL
$5.43 - $11.4 $1,086 - $2,280
-200 Reduced 9.25%
1,963 $14,000
Q4 2021

Feb 14, 2022

BUY
$10.96 - $11.87 $23,706 - $25,674
2,163 New
2,163 $24,000

Others Institutions Holding GNTA

About Genenta Science S.p.A.


  • Ticker GNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,216,900
  • Market Cap $89.3M
  • Description
  • Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...
More about GNTA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.